CSIMarket Company Name, Ticker, Suppliers, else..
 
Immucell Corporation  (NASDAQ: ICCC)
 
Price: $9.9000 $-0.10 -1.000%
Day's High: $9.970000267028809 Week Perf: 1.12 %
Day's Low: $ 9.80 30 Day Perf: -10.16 %
Volume (M): 11,695 52 Wk High: $ 12.10
Volume (M$): $ 0 52 Wk Avg: $7.64
Open: $9.97 52 Wk Low: $4.52



 Market Capitalization (Millions $) 91
 Shares Outstanding (Millions) 9
 Employees 73
 Revenues (TTM) (Millions $) 30
 Net Income (TTM) (Millions $) 1
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 2

Business Description


Immucell Corp is a biotechnology company that focuses on developing and producing innovative solutions for animal health. The company specializes in the production of veterinary vaccines and other immune-stimulating products. Immucell's goal is to improve the health and productivity of animals by providing effective and safe immunological solutions. They have a range of products for various species such as cattle, poultry, and swine. Immucell Corp is committed to research and development, ensuring the continuous advancement of their products and contributing to the welfare of animals worldwide.


   Company Address: 56 Evergreen Drive Portland 4103 ME
   Company Phone Number: 878-2770   Stock Exchange / Ticker: NASDAQ ICCC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
IDXX   -3.53%    
VXRT   -1.3%    
• View Complete Report
   



Product Service News

ImmuCells Bold Leap Re-Tain Set to Revolutionise Animal Health Amidst Financial Turnaround,

Published Thu, Apr 3 2025 2:54 AM UTC

ImmuCell Marks a Milestone with Investigational Product Launch: Re-Tain Set to Transform Animal Health Industry In the bustling heart of Portland, Maine, a promising shift is underway in the realm of animal health. ImmuCell Corporation (Nasdaq: ICCC), an innovative player dedicated to enhancing dairy and beef cattle health, has announced the initiation of investigational pro...
Product Service News

ImmuCells Regulatory Progress on Re-Tain: A Game Changer for Dairy and Beef Cattle Health

Published Wed, Jun 5 2024 8:05 PM UTC

PORTLAND, Maine, June 05, 2024 - ImmuCell Corporation (Nasdaq: ICCC), a burgeoning animal health company, is making waves with its latest regulatory update on its product development initiative for Re-Tain. Here are the key points you need to know about this potentially transformative development. Re-Tain: A Quick Overview Re-Tain is a promising product developed by ImmuCel...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 141.43
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 3.06
Price to Sales (Expected) -
Price to Book 2.9
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.51
Working Capital Ratio 3.6
Leverage Ratio (MRQ) 0.49
Total Debt to Equity 0.31
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.35

Per Share Current
Earnings (TTM) 0.07 $
Revenues (TTM) 3.24 $
Cash Flow (TTM) 0.09 $
Cash 0.96 $
Book Value 3.41 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 407,900
Net Income per Employee (TTM) 10,786
Receivable Turnover Ratio (TTM) 10.3
Inventory Turnover Ratio (TTM) 1.89
Asset Turnover Ratio (TTM) 0.67

Profitability Ratios Current
Gross Margin (MRQ) 33.92 %
Operating Margin (MRQ) 26.93 %
Net Margin (MRQ) 25.53 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 7.76 %

Management Effectiveness Current
Return On Assets (TTM) 1.76 %
Return On Investment (TTM) 1.95 %
Return On Equity (TTM) 2.68 %
Dividend Yield -
Pay out Ratio (TTM) -



Immucell's Segments
US    222.1 % of total Revenue
Non Us    22.03 % of total Revenue
Corporate Segment Scours    242.4 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.